Delivery Order SPE2DR25D9831-SPE2DR26FRPB2
- Not listed
- The Defense Logistics Agency awarded a $1,670.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is...
- The Defense Logistics Agency issued a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1-dose vials. This firm fixed-price delivery order, awarded on November 26, 2025, with an ultimate completion date of December 18, 2025, contains no set-aside designation, indicating the award was made through unrestricted federal procurement. The order was issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $2,783.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The place of performance is listed as Park Ridge, IL 60068, and the delivery order represents pharmaceutical supply to support federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was awarded on September 3, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of June 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park Ridge, IL. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation, allowing the contractor to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a $106,897.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The award was issued on October 22, 2025, with an ultimate completion date of November 13, 2025. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- The Defense Logistics Agency awarded a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is firm fixed-price with an ultimate completion date of October 8, 2025, and was awarded on September 17, 2025. This delivery order is issued without a set-aside designation and represents a continuation of DMS Pharmaceutical Group's substantial...
- The Defense Logistics Agency issued a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The delivery order, awarded on November 5, 2025, with an ultimate completion date of November 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's recently awarded Indefinite Delivery...
- SPE2DR25D9831Indefinite Delivery Contract
- SPE2DR25D9831-SPE2DR26FRPB2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing with no set-aside designation. This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under the agency's pharmaceutical supply chain operations, reflecting the company's established capability to provide critical pharmaceutical products to federal military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare operations worldwide. The prime vendor contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's performance across its extensive product portfolio, which includes vaccines such as YF-VAX along with oncology treatments, immunosuppressants, and specialty pharmaceuticals, demonstrates its role as a critical supplier within the federal military medical system with no identified subcontractor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 11/30/25 |